preceding researches with neuropathic pain models demonstrated significant anti-nociceptive effects of systemic or intrathecal administration of dexmedetomidine. [4] [5] [6] Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), has analgesic activity and its systemic administration is widely practiced for the clinical treatment of postoperative and cancer pain. 7 The induction of analgesia by intrathecal ketorolac has also been demonstrated in a variety of animal models of pain. 8, 9 The objective of this research is to identify the synergistic effect of intrathecal administration of dexmedetomidine and ketorolac on mechanical allodynia alleviation in SNL rats.
MATERIALS AND METHODS
The experimental protocol was approved by the Institutional Animal Care and Use Committee. A separate cage was used for each of them in a temperature controlled room (23 ± 0.5℃) with a 12/12-hr light/dark cycle. They were allowed free access to food and water. An established procedure was used for ligating the spinal nerve L5 of adult Sprague-Dawley rats (250 -300 g). 10 The animals were anesthetized by delivering sevoflurane through a nose cone. Skin incision, at the midline over the lumbar spine, was carried out under aseptic condition. The left transverse process of the L6 vertebra was removed, followed by the dissection of the exposed left L5 spinal nerve from the underlying tissue. Then the left L5 spinal nerve, cut distally, was ligated using a 6-0 silk suture. After the surgery, the rats were again kept in the cages under the monitoring of their recovery.
7 days after the surgery, intrathecal catheterization was conducted by an established method so as to allow drug injection. 11 The catheter of a saline-filled polyethylene-10 tubing was implanted to thoracic vertebrae by being inserted (6-7 ㎝) into a small slit made on the atlanto-occipital membrane.
All the rats that had undergone SNL were div- PWT was determined, using the formula of 
RESULTS
At 1, 2, and 4 hr after drug injection, on 3 consecutive days beginning on the 10th day after SNL, statistically significant increases in ipsilateral PWTs were shown by groups D and K compared to group S (P < 0.05), and by Group DK compared to groups D and K (P < 0.05) (Fig. 1) . No significant change in contralateral PWT was observed after the treatments (Data not presented).
As for % pre-SNL in ipsilateral paw, significantly higher PWTs were shown by groups D and K compared to group S (P < 0.05), and by group DK compared to groups D and K SNL (P < 0.05) at 1, 2, and 4 hr after drug injection, on 3 consecutive days beginning on the 10th day after SNL (Fig.   2 ).
DISCUSSION
In this research involving rats, 3 consecutive days of measurements, beginning on the 10th day after SNL and taken at 1, 2, and 4 hr after intrathecal drug injection, all resulted in significant increase in PWT in the groups which received either dexmedetomidine or ketorolac compared to the group which received normal saline; while the group which received both dexmedetomidine and ketorolac simultaneously always showed significantly higher PWT than the groups which received only one of them. Thus it could be inferred that simultaneous administration of dexmedetomidine and ketorolac is more effective for neuropathic pain alleviation than the administration of only one of them. Although the mechanism of dexmedetomidine and ketorolac action is beyond the scope of the present research, some preceding researches on neuropathic pain concerned the mechanism of their action.
Neuropathic pain caused by peripheral nerve 14 They all act through a common pharmacological mechanism involving the activation of spinal α 2-adrenoceptors, which play a critical role in neuropathic pain suppression. 15, 16 Activated spinal α2-adrenoceptors directly inhibit nociceptive neurotransmission by suppressing the release of such neurotransmitters as substance P and glutamate from primary afferent terminals, and also by hyperpolarizing dorsal horn neurons via G-protein-mediated activation of potassium channels. 17, 18 Preceding researches suggest that intrathecal clonidine, an agonist of α2-adrenoceptor, enhances potency and efficacy against neuropathic pains in animals as well as in human. 19, 20 It is considered that such an effect is mediated via downstream activation of inhibitory cholinergic interneurons. That is, an α2-adrenoceptor agonist, which inhibits spinal cholinergic interneurons in normal condition, rather excites them in response to nerve injury, and the consequent release of acetylcholine (ACh) is believed to be cru- Prostaglandins play an important role in the spinal level of augmented processing of pain information. 23 Intrathecal injection of prostaglandins E2 (PGE2) and D2 (PGD2) was shown to induce hyperalgesia and allodynia in mice. 25 Whereas NSAIDs was also shown to alleviate the behavioral hyperalgesia caused by the spinal action of N-methyl-D-aspartate (NMDA) and substance P. 23 There have been researches on the analgesic activity of intrathecal ketorolac in various pain models, which include formalin test in rats as well as acetic acid writhing test or p-phenylquinone test in mice. 8, 9, 26, 27 According to the result of the formalin test, intrathecal ketorolac inhibited phase 2 pain response, but with only a limited effect on phase I pain response. 
